These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24643697)

  • 1. The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study.
    Manes C; Papanas N; Exiara T; Katsiki N; Papantoniou S; Kirlaki E; Tsotoulidis S; Kefalogiannis N; Maltezos E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):195-9. PubMed ID: 24643697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes.
    Ziegler D; Papanas N; Roden M;
    Diabet Med; 2011 Nov; 28(11):1412-5. PubMed ID: 21658119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Kotsiou S; Maltezos E
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):122-5. PubMed ID: 20690070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic accuracy of Neuropad for assessing large and small fibre diabetic neuropathy.
    Ponirakis G; Petropoulos IN; Fadavi H; Alam U; Asghar O; Marshall A; Tavakoli M; Malik RA
    Diabet Med; 2014 Dec; 31(12):1673-80. PubMed ID: 24975286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.
    Papanas N; Papatheodorou K; Christakidis D; Papazoglou D; Giassakis G; Piperidou H; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):195-8. PubMed ID: 15891953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuropad test: a visual indicator test for human diabetic neuropathy.
    Quattrini C; Jeziorska M; Tavakoli M; Begum P; Boulton AJ; Malik RA
    Diabetologia; 2008 Jun; 51(6):1046-50. PubMed ID: 18368386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA; Petrova JJ; Christov VG
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropad for the detection of cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Mendivil CO; Kattah W; Orduz A; Tique C; Cárdenas JL; Patiño JE
    J Diabetes Complications; 2016; 30(1):93-8. PubMed ID: 26525688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes.
    Bilen H; Atmaca A; Akcay G
    Adv Ther; 2007; 24(5):1020-7. PubMed ID: 18029328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Diabetes Educ; 2007; 33(2):257-8, 260, 262 passim. PubMed ID: 17426301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey.
    Ziegler D; Papanas N; Rathmann W; Heier M; Scheer M; Meisinger C;
    Diabetes Metab Res Rev; 2012 Nov; 28(8):692-7. PubMed ID: 22949335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication.
    Papanas N; Papatheodorou K; Papazoglou D; Christakidis D; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):577-81. PubMed ID: 16320155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of peripheral arterial occlusive disease on the Neuropad(®) test performance in patients with diabetes.
    Aubert CE; Le Doeuff J; Lajou J; Barthelemy O; Hartemann A; Bourron O
    Diabet Med; 2013 May; 30(5):e178-84. PubMed ID: 23398465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):58-61. PubMed ID: 17286238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
    Zografou I; Iliadis F; Sambanis C; Didangelos T
    Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy.
    Ponirakis G; Fadavi H; Petropoulos IN; Azmi S; Ferdousi M; Dabbah MA; Kheyami A; Alam U; Asghar O; Marshall A; Tavakoli M; Al-Ahmar A; Javed S; Jeziorska M; Malik RA
    J Diabetes Res; 2015; 2015():847854. PubMed ID: 26064991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Useful application of the Neuropad test for assessment of diabetic polyneuropathy.
    Yoshioka K; Okada H
    Intern Med; 2012; 51(23):3241-5. PubMed ID: 23207118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of limited joint mobility and foot deformities with neurological examination in patients with diabetes.
    Sanz-Corbalán I; Lázaro-Martínez JL; García-Morales E; Aragón-Sánchez J; Carabantes-Alarcón D; García-Álvarez Y
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):239-43. PubMed ID: 23329582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.